Below are some upcoming continuing medical education (CME) events being offered by NAMEC members.
NASH: The Epidemic Is Here, Are You Ready?
San Diego, CA - Manchester Grand Hyatt – Harbor Room Ballroom A/B/C
May 18, 2019 @ 6:15 pm
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), relatively unknown just 2 decades ago, are now the most common causes of chronic liver disease worldwide, affecting an estimated 25% of the world's population. The collective epidemic of NAFLD and NASH closely parallels the epidemics of obesity and type 2 diabetes mellitus. As the prevalence of these conditions continues to increase, predictions are that the prevalence of NAFLD and NASH will also increase, creating an unprecedented clinical and economic burden. Early disease can be managed with modification of risk factors in some individuals. There are no approved drug regimens to treat NASH, but the clinical trial pipeline is very active. A panel of leading experts will emphasize the importance of early detection and diagnosis as a means to halting the epidemic through either preventing progression of disease or in the future, treatment.
Paradigm Medical Communications, LLC
Every Breath You Take: A Case-based Approach to Improving Diagnosis, Treatment, and Management of Patients with COPD
Online Activity available through May 31, 2019
Upon proper completion of this activity, participants should be better able to:
Identify early signs and symptoms of chronic obstructive pulmonary disease that warrant further evaluation with guideline-recommended tools and tests.
Describe evidence-based tools and strategies for determining the severity of chronic obstructive pulmonary disease, including their utility in directing appropriate therapy.
Select treatment options for chronic obstructive pulmonary disease by applying information about agent, patient, and disease characteristics.
Choose a medication delivery device for patients with chronic obstructive pulmonary disease that accords with patient needs, preferences, and capabilities.
Academy for Continued Healthcare Learning (ACHL)
Kansas City Heart Rhythm Symposium 2019
Overland Park, KS - Sheraton Overland Park Hotel
August 17-18, 2019
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trials that have helped change the clinical practice of EP will also be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage (LAA) treatment options and gain a greater understanding of anticoagulation and stroke prophylaxis.
North American Center for Continuing Medical Education, LLC (NACCME)
Mitigating the Cost Burden of PAH: Evaluating the Value of Timely Treatment with Effective Therapy
Online Activity available through March 10, 2020
After participating in this activity, participants should be better able to:
Quantify the clinical and economic burdens associated with the delayed diagnosis, suboptimal treatment, and consequent hospitalization of patients with PAH
Evaluate clinical data regarding the PAH-specific therapies as well as their mechanism of action, efficacy, safety, and implications on mitigating healthcare utilization and costs
Develop diagnostic, treatment, and follow-up protocols for PAH that reflect guideline recommendations and current clinical evidence and support individualized PAH care
Inform formulary placement and benefit design decisions with the latest cost data, treatment guidelines, and optimal PAH management strategies